Picture of Zoetis logo

ZTS Zoetis News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Zoetis Inc reports results for the quarter ended December 31 - Earnings Summary

* Zoetis Inc  ZTS.N  reported quarterly adjusted earnings of
$1.40​​ per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of
$1.24.  The mean expectation of fourteen analysts for the
quarter was for earnings of $1.34 per share. Wall Street
expected results to range from $1.05  to $1.42 per share.
    * Revenue rose 4.7% to $2.32 billion from a year ago;
analysts
expected $2.30 billion. 
    * Zoetis Inc's reported EPS for the quarter was $1.29​.
    * The company reported quarterly net income of $581 million.
    * Zoetis Inc shares had risen by 6.7% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.6%
in the last three months.​ 
    * In the last 30 days, five analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 16 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Zoetis Inc is
$205.00 
This summary was machine generated from LSEG data February 13 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      1.34           1.40           Beat
 Sep. 30 2024      1.46           1.58           Beat
 Jun. 30 2024      1.49           1.56           Beat
 Mar. 31 2024      1.34           1.38           Beat

Recent news on Zoetis

See all news